Cargando…
The role of modulators in cystic fibrosis related diabetes
The development and introduction of modulator therapies have completely shifted the paradigm for the treatment of cystic fibrosis (CF). Highly effective modulator therapies have driven marked improvements in lung function, exacerbation rate, weight and quality of life in CF patients. However, their...
Autores principales: | Merjaneh, Lina, Hasan, Sana, Kasim, Nader, Ode, Katie Larson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668978/ https://www.ncbi.nlm.nih.gov/pubmed/34917484 http://dx.doi.org/10.1016/j.jcte.2021.100286 |
Ejemplares similares
-
Pediatric Case Series of Cystic Fibrosis, Diabetes, and Islet Cell Autoimmunity
por: Kim, Grace J., et al.
Publicado: (2018) -
A provider survey of cystic fibrosis related diabetes screening and management practices at North American CF centers
por: Hicks, Rebecca, et al.
Publicado: (2023) -
Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis
por: Khare, Swapnil, et al.
Publicado: (2021) -
Impaired Fasting Glucose in Cystic Fibrosis
por: Frohnert, Brigitte I., et al.
Publicado: (2010) -
The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
por: Hasan, Sana, et al.
Publicado: (2022)